Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
162M
-
Number of holders
-
216
-
Total 13F shares, excl. options
-
177M
-
Shares change
-
+2.9M
-
Total reported value, excl. options
-
$2.32B
-
Value change
-
+$38.2M
-
Put/Call ratio
-
0.2
-
Number of buys
-
111
-
Number of sells
-
-84
-
Price
-
$13.06
Significant Holders of IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) as of Q3 2021
248 filings reported holding IRWD - IRONWOOD PHARMACEUTICALS INC - Class A Common Stock as of Q3 2021.
IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) has 216 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 177M shares
.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (17.5M shares), BROWN CAPITAL MANAGEMENT LLC (17M shares), Sarissa Capital Management LP (16.4M shares), VANGUARD GROUP INC (13.5M shares), BlackRock Inc. (12.5M shares), WESTFIELD CAPITAL MANAGEMENT CO LP (8.18M shares), LSV ASSET MANAGEMENT (7.81M shares), STATE STREET CORP (7.43M shares), Camber Capital Management LP (5.5M shares), and PUTNAM INVESTMENTS LLC (5.48M shares).
This table shows the top 216 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.